Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ganglia, Spinal | 12 | 2012 | 12 | 2.700 |
Why?
|
| Neurons | 6 | 2011 | 41 | 1.520 |
Why?
|
| Calcium | 12 | 2012 | 35 | 1.440 |
Why?
|
| Sensory Receptor Cells | 3 | 2012 | 3 | 1.260 |
Why?
|
| Estrogen Receptor alpha | 4 | 2012 | 14 | 1.210 |
Why?
|
| Estradiol | 6 | 2012 | 50 | 1.150 |
Why?
|
| Colon | 5 | 2008 | 16 | 1.060 |
Why?
|
| Estrogen Receptor beta | 4 | 2012 | 10 | 1.010 |
Why?
|
| Receptors, Purinergic P2X3 | 3 | 2012 | 3 | 0.960 |
Why?
|
| Uterus | 3 | 2008 | 12 | 0.960 |
Why?
|
| Adenosine Triphosphate | 6 | 2012 | 12 | 0.920 |
Why?
|
| Animals | 19 | 2012 | 1238 | 0.810 |
Why?
|
| TRPV Cation Channels | 2 | 2012 | 4 | 0.770 |
Why?
|
| Calcium Signaling | 3 | 2012 | 5 | 0.770 |
Why?
|
| Visceral Afferents | 3 | 2012 | 3 | 0.740 |
Why?
|
| Cells, Cultured | 12 | 2012 | 164 | 0.640 |
Why?
|
| Rats | 12 | 2011 | 432 | 0.620 |
Why?
|
| Female | 10 | 2012 | 1733 | 0.530 |
Why?
|
| Rats, Long-Evans | 7 | 2011 | 7 | 0.520 |
Why?
|
| Neurons, Afferent | 2 | 2007 | 2 | 0.510 |
Why?
|
| Estrogens | 2 | 2011 | 25 | 0.470 |
Why?
|
| Substance P | 4 | 2010 | 6 | 0.460 |
Why?
|
| Nociception | 1 | 2012 | 2 | 0.440 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2011 | 2 | 0.420 |
Why?
|
| Pain | 2 | 2010 | 24 | 0.420 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 17 | 0.410 |
Why?
|
| Receptors, Estrogen | 2 | 2011 | 35 | 0.350 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 7 | 0.340 |
Why?
|
| Astrocytes | 2 | 2006 | 6 | 0.330 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 1 | 0.330 |
Why?
|
| Calcium Channels | 3 | 2004 | 6 | 0.310 |
Why?
|
| Mice | 4 | 2012 | 508 | 0.300 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2004 | 20 | 0.300 |
Why?
|
| Protein Kinase C | 2 | 2004 | 5 | 0.290 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 133 | 0.290 |
Why?
|
| Mice, Knockout | 3 | 2012 | 112 | 0.280 |
Why?
|
| Nociceptors | 3 | 2010 | 9 | 0.250 |
Why?
|
| Mechanoreceptors | 1 | 2001 | 1 | 0.210 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 74 | 0.200 |
Why?
|
| Analysis of Variance | 2 | 2008 | 39 | 0.150 |
Why?
|
| Physical Stimulation | 4 | 2004 | 4 | 0.140 |
Why?
|
| Enzyme Inhibitors | 4 | 2004 | 45 | 0.130 |
Why?
|
| Protein Binding | 1 | 2012 | 17 | 0.110 |
Why?
|
| Xanthenes | 1 | 2011 | 1 | 0.100 |
Why?
|
| Amino Acids | 1 | 2011 | 16 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 185 | 0.100 |
Why?
|
| Microscopy, Video | 1 | 2010 | 2 | 0.090 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2010 | 2 | 0.090 |
Why?
|
| Inflammation | 1 | 2010 | 44 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2008 | 15 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 1999 | 29 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2008 | 68 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2008 | 8 | 0.080 |
Why?
|
| Intracellular Membranes | 2 | 2006 | 6 | 0.080 |
Why?
|
| Osmolar Concentration | 2 | 2006 | 43 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 179 | 0.080 |
Why?
|
| Afferent Pathways | 1 | 2007 | 1 | 0.080 |
Why?
|
| Hypogastric Plexus | 1 | 2007 | 1 | 0.080 |
Why?
|
| Pelvic Pain | 1 | 2007 | 1 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 3 | 0.080 |
Why?
|
| Progesterone | 1 | 2006 | 9 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2006 | 47 | 0.070 |
Why?
|
| Maleimides | 2 | 2004 | 6 | 0.070 |
Why?
|
| Indoles | 2 | 2004 | 8 | 0.070 |
Why?
|
| Drug Interactions | 2 | 2003 | 18 | 0.070 |
Why?
|
| Aging | 1 | 2006 | 101 | 0.070 |
Why?
|
| Calcium Channel Blockers | 2 | 2003 | 5 | 0.070 |
Why?
|
| Pain Threshold | 1 | 2005 | 5 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 7 | 0.070 |
Why?
|
| Sex Factors | 1 | 2005 | 75 | 0.070 |
Why?
|
| Gadolinium | 2 | 2001 | 2 | 0.060 |
Why?
|
| Lanthanum | 2 | 2001 | 2 | 0.060 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2004 | 1 | 0.060 |
Why?
|
| N-Methylaspartate | 1 | 2004 | 1 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2004 | 1 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 3 | 0.060 |
Why?
|
| Potassium Chloride | 1 | 2003 | 4 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2003 | 6 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2003 | 4 | 0.060 |
Why?
|
| Cholecystokinin | 1 | 2002 | 2 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2002 | 4 | 0.060 |
Why?
|
| Opioid Peptides | 1 | 2002 | 16 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 118 | 0.060 |
Why?
|
| Brain | 1 | 2002 | 55 | 0.060 |
Why?
|
| Trachea | 2 | 1999 | 4 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2001 | 1 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2001 | 2 | 0.050 |
Why?
|
| Antibodies | 1 | 2001 | 9 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2001 | 9 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2001 | 30 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2001 | 54 | 0.050 |
Why?
|
| Benzyl Compounds | 1 | 2000 | 1 | 0.050 |
Why?
|
| Capsaicin | 1 | 2000 | 1 | 0.050 |
Why?
|
| Propylamines | 1 | 2000 | 1 | 0.050 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2000 | 3 | 0.050 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2000 | 4 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 36 | 0.040 |
Why?
|
| Gravitation | 1 | 1998 | 1 | 0.040 |
Why?
|
| Weightlessness | 1 | 1998 | 3 | 0.040 |
Why?
|
| Thapsigargin | 3 | 2006 | 3 | 0.040 |
Why?
|
| Signal Transduction | 1 | 1998 | 180 | 0.040 |
Why?
|
| Kinetics | 3 | 2000 | 44 | 0.030 |
Why?
|
| Rabbits | 3 | 1999 | 25 | 0.030 |
Why?
|
| Cell Membrane | 2 | 1999 | 31 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 2006 | 4 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 54 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2006 | 167 | 0.020 |
Why?
|
| Male | 2 | 2001 | 1649 | 0.020 |
Why?
|
| Lordosis | 1 | 2002 | 1 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 2002 | 1 | 0.010 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2001 | 1 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2001 | 8 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 45 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 62 | 0.010 |
Why?
|
| Amiloride | 1 | 2000 | 1 | 0.010 |
Why?
|
| Naltrexone | 1 | 2000 | 15 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 37 | 0.010 |
Why?
|
| Ryanodine | 1 | 1999 | 1 | 0.010 |
Why?
|
| Nifedipine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Caffeine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 1999 | 6 | 0.010 |
Why?
|
| Diglycerides | 1 | 1999 | 1 | 0.010 |
Why?
|
| Oscillometry | 1 | 1999 | 1 | 0.010 |
Why?
|
| Carbazoles | 1 | 1999 | 2 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 5 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1999 | 10 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 29 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1998 | 2 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1998 | 3 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1998 | 6 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 13 | 0.010 |
Why?
|